|
Keynote Forum |
|
|
Day 1: Morning, May 11, 2022 |
|
|
Moderator |
Call for Moderator |
|
Time |
Speeches and Speakers |
|
09:00-09:05 |
Chair's Introduction |
|
09:05-09:30 |
Title: The First Biomarker-Driven Blockbuster Drug Discovery: Herceptin Dr. H. Michael Shepard, President and CEO, Enosi Life Sciences, USA 2019 Lasker Awards |
|
09:30-09:55 |
Speech Opportunity Available |
|
09:55-10:20 |
Title: Cell-penetrating Peptides and Drug Delivery Dr. Ulo Langel, Professor, Stockholm University, Sweden Member of the Academia Europaea; Foreign Member of Estonian Academy of Science |
|
10:20-10:45 |
Title: Genomes, Structural Biology and Drug Discovery: Combating the Impacts of Mutations in Genetic Disease and Antibiotic Resistance Dr. Tom Blundell, Professor, Department of Biochemistry, University of Cambridge, UK Member of Academia Europaea; Fellow of the Royal Society; Fellow of Academy of Medical Sciences |
|
10:45-11:10 |
Speech Opportunity Available |
|
11:10-11:35 |
Speech Opportunity Available |
|
Session 1-1: Enhancing Bioavailability with New Technologies and Strategies |
|
|
Day 1: Afternoon, May 11, 2022 |
|
|
Chair |
Call for Chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Speech Opportunity Available |
|
14:00-14:25 |
Speech Opportunity Available |
|
14:25-14:50 |
Speech Opportunity Available |
|
14:50-15:15 |
Title: TBD Dr. Soon-Mi Shim, Professor, Department of Food Science and Biotechnology, School of Biological Science and Technology, Sejong University, South Korea |
|
15:15-15:30 |
Coffee Break |
|
Session 2-1: Advances in Drug Delivery Technologies |
|
|
Day 1: Afternoon, May 11, 2022 |
|
|
Chair
|
Dr. Susan W. Neadle, Sr. Director, Global Value Chain Quality Design; Head, Combination Products CoP, Johnson & Johnson, USA
|
| Co-Chair | Dr. Nian-Qiu Shi, Vice-dean of School of Pharmacy, Department of pharmaceutics, School of Pharmacy, Jilin Medical University, China |
|
Time |
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Keynote Speech Title: Understanding Tablet Properties Using USP<1062> Using a Laboratory Tablet Press Dr. Michael J Gamlen, Chief Scientific Officer, Gamlen Tableting Ltd, UK |
|
14:00-14:25 |
Title: A Look at Emerging Delivery Systems for Topical Drug Products Dr. Ofer Toledano, Vice President of Research and Development, Sol-Gel Technologies Ltd, Israel |
|
14:25-14:50 |
Title: Combination Products Integrated Development and Risk Management Dr. Susan W. Neadle, Sr. Director, Global Value Chain Quality Design; Head, Combination Products CoP, Johnson & Johnson, USA |
|
14:50-15:15 |
Speech Opportunity Available |
|
15:15-15:30 |
Coffee Break |
|
15:30-15:55 |
Title: A Doxycycline-loaded Polymer-lipid Encapsulation Matrix for the Prevention of Surgical Site Infections Dr. Shaul Mukhtar, EVP, COO, PolyPid, Israel |
|
15:55-16:20 |
Title: TBD Dr. Pierandrea Esposito, Founder and Associate Director, SiTec PharmaBio, Spain |
|
16:20-16:45 |
Title: Hot Melt Extrusion Technology for Improved Dissolution Solubility and Spring-parachute Processes Dr. Nian-Qiu Shi, Vice-dean of School of Pharmacy, Department of pharmaceutics, School of Pharmacy, Jilin Medical University, China |
|
16:45-17:10 |
Speech Opportunity Available |
|
Session 3-1: New Oral, Transmucoadhesive, and Buccal Drug Delivery |
|
|
Day 1: Afternoon, May 11, 2022 |
|
|
Chair |
Call for Chair |
| Co-Chair | Dr. Stine Harloff-Helleberg, Assistant Professor, University of Copenhagen, Denmark |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Speech Opportunity Available |
|
14:00-14:25 |
Title: TBD Dr. Alexander Vilesov, Laboratory Head, Pavlov First Saint Petersburg State Medical University, Russia |
|
14:25-14:50 |
Title: Understanding Mucosal Drug Delivery by Uncovering the Interaction between Delivery System and Mucus Dr. Stine Harloff-Helleberg, Assistant Professor, University of Copenhagen, Denmark |
|
14:50-15:15 |
Title: TBD
Dr. Irina M. Yermak, Professor, Head, Pacific Institute of Bioorganic Chemistry, Far-Eastern Branch of the Russian Academy of Sciences, Russia |
|
15:15-15:30 |
Coffee Break |
|
Session 5-1: Molecule Drugs Formulation |
|
|
Day 1: Afternoon, May 11, 2022 |
|
|
Chair |
Call for Chair |
|
Time |
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Speech Opportunity Available |
|
14:00-14:25 |
Title: Novel Calcium Delivery Systems to Treat Skin Disorders Dr. Fred Zuelli, Founder, Business Development Director, Mibelle Group Biochemistry, Switzerland |
|
14:25-14:50 |
Title: TBD Dr. Frank J. Burczynski, Professor, Department of Pharmacology & Therapeutics, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Canada |
|
14:50-15:15 |
Title: TBD Dr. Rajesh Pate, Senior VP, Titan Pharmaceutical, USA |
|
15:15-15:30 |
Coffee Break |
|
© 2003-2022 All rights reserved by BIT Group Global Ltd. |